相关实验视频

Updated: May 12, 2026

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Published on: December 28, 2014

通过使用18F-米索尼二醇正子发射断层扫描对低氧成像进行审查

Kenji Hirata^1,2,3, Shiro Watanabe^4,5,6, Yoshimasa Kitagawa⁷

¹Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. khirata@med.hokudai.ac.jp.

Methods in molecular biology (Clifton, N.J.)

|February 6, 2024

概括

使用[18F]化胺醇 ([18F]FMISO) 的正子发射断层扫描 (PET) 可以识别瘤缺氧,这是癌症恶性和治疗耐药性的关键因素. 这种方法为[18F]氧葡萄糖 (FDG) -PET提供了替代方案,尽管它需要更长的成像等待期.

科学领域:

在瘤学瘤学.
核医学是一种核医学.
放射化学放射化学是指辐射化学.

背景情况:

瘤缺氧是影响癌症恶性病变,患者预后和治疗耐药性的关键因素.
聚子发射断层扫描 (PET) 是一种强大的成像技术,用于在体内可视化放射性药物分布.
识别和表征瘤缺氧对于有效的癌症管理至关重要.

研究的目的:

评估[18F]化胺醇 ([18F]FMISO) PET成像用于检测瘤缺氧的实用性.
将[18F]FMISO-PET与其他成像模式进行比较,并讨论其优点和局限性.
突出新型缺氧追踪剂的潜力.

主要方法:

使用[18F]米松醇 ([18F]FMISO) 作为PET标记物来识别缺氧瘤组织.
在注射后相对较长的等待时间 (2-4小时) 后获得的PET图像.
探索视觉评估和定量指数 (例如,瘤与肌肉的比例) 用于图像分析.

主要成果:

[18F]FMISO-PET成功地可视化了缺氧组织.
与[18F]氧葡萄糖 ([18F]FDG) -PET不同,[18F]FMISO-PET不需要患者禁食.
图像与标准PC观看器兼容,方便临床解释.

结论:

[18F]FMISO-PET是评估瘤缺氧的可行方法.
该技术比[18F]FDG-PET具有实用优势,例如不需要禁食.
持续开发新的缺氧追踪剂旨在克服[18F]FMISO的局限性,例如延长成像时间.

关键词:

缺氧是放射性标志物中的一种.在这里,PET是PET.定子发射断层扫描 (PET) 是一种定子发射断层扫描.[14C] 迷思尼达 (misonidazole) 是一种药物.[18F]FMISO的标准是什么 [18F]FMISO-PET是什么意思 [18F]氧化葡萄糖.[18F]米松尼达醇的使用

更多相关视频

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

Published on: September 20, 2015

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET